123 related articles for article (PubMed ID: 4856355)
1. Levodopa and melanoma.
Lieberman AN; Shupack JL
Neurology; 1974 Apr; 24(4):340-3. PubMed ID: 4856355
[No Abstract] [Full Text] [Related]
2. Levodopa and malignant melanoma.
Robinson E; Wajsbort J; Hirshowitz B
Arch Pathol; 1973 Mar; 95(3):213. PubMed ID: 4686512
[No Abstract] [Full Text] [Related]
3. Multiple primary melanoma following administration of levodopa.
Skibba JL; Pinckley J; Gilbert EF; Johnson RO
Arch Pathol; 1972 Jun; 93(6):556-61. PubMed ID: 5025039
[No Abstract] [Full Text] [Related]
4. Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature.
Kochar AS
Am J Med; 1985 Jul; 79(1):119-21. PubMed ID: 4014296
[TBL] [Abstract][Full Text] [Related]
5. Levodopa and melanoma.
N C Med J; 1973 Jun; 34(6):448 passim. PubMed ID: 4197142
[No Abstract] [Full Text] [Related]
6. [Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship].
Happle
Fortschr Med; 1974 Sep; 92(27):1065-6. PubMed ID: 4457419
[No Abstract] [Full Text] [Related]
7. Melanoma, eruptive naevi and natalizumab: Causal relation or coincidence?
Munguía-Calzada P; Vivanco B; Oliva-Nacarino P; Santos-Juanes J
Australas J Dermatol; 2017 Nov; 58(4):330-331. PubMed ID: 28925067
[No Abstract] [Full Text] [Related]
8. Pseudomelanoma after Solcoderm treatment.
Grunwald MH; Gat A; Amichai B
Melanoma Res; 2006 Oct; 16(5):459-60. PubMed ID: 17013096
[TBL] [Abstract][Full Text] [Related]
9. Hutchinson's melanotic freckle melanoma associated with non-permanent hair dyes.
Holman CD; Armstrong BK
Br J Cancer; 1983 Oct; 48(4):599-601. PubMed ID: 6626457
[No Abstract] [Full Text] [Related]
10. Darkening and eruptive nevi during treatment with erlotinib.
Hemperly S; Ermolovich T; Lountzis NI; Sheikh HA; Purcell SM
Cutis; 2019 Jul; 104(1):E19-E21. PubMed ID: 31487352
[No Abstract] [Full Text] [Related]
11. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
Pfützner W; Przybilla B
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541
[TBL] [Abstract][Full Text] [Related]
12. Levodopa, melanoma, and Parkinson's disease.
Weiner WJ; Singer C; Sanchez-Ramos JR; Goldenberg JN
Neurology; 1993 Apr; 43(4):674-7. PubMed ID: 8469320
[TBL] [Abstract][Full Text] [Related]
13. Levodopa and melanoma: three cases and review of literature.
Rampen FH
J Neurol Neurosurg Psychiatry; 1985 Jun; 48(6):585-8. PubMed ID: 4009196
[TBL] [Abstract][Full Text] [Related]
14. Levodopa therapy and malignant melanoma.
Sober AJ; Wick MM
JAMA; 1978 Aug; 240(6):554-5. PubMed ID: 671667
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
Dupont E; Hansen E; Melsens S; Parkenberg H; Holm P
Acta Neurol Scand Suppl; 1972; 51():115-7. PubMed ID: 4514334
[No Abstract] [Full Text] [Related]
16. MK 486 and levodopa in treatment of Parkinsonism.
Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F
Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885
[No Abstract] [Full Text] [Related]
17. [Treatment of Parkinson's disease with levodopa].
Sigwald J; Raymondeaud C; Grégoire J
Therapeutique; 1972 Nov; 48(9):543-54. PubMed ID: 4650524
[No Abstract] [Full Text] [Related]
18. Treatment failures with levodopa in Parkinsonism.
Lieberman AN; Goodgold AL; Goldstein M
Neurology; 1972 Nov; 22(11):1205-10. PubMed ID: 4673563
[No Abstract] [Full Text] [Related]
19. [Melanoma and dysplastic nevus after 8 years of topical Caryolysine].
Cosnes A; Revuz J; Wechsler J; Touraine R
Ann Dermatol Venereol; 1984; 111(2):127-32. PubMed ID: 6721359
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Parkinson's disease with levodopa and Ro 4-4602.
Barbeau A; Gillo-Joffroy L; Mars H
Clin Pharmacol Ther; 1971; 12(2):353-9. PubMed ID: 4930866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
